These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18634374)

  • 1. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.
    Han SH; Choi SH; Cho BJ; Lee Y; Lim S; Park YJ; Moon MK; Lee HK; Kang SW; Han DS; Kim YB; Jang HC; Park KS
    Metabolism; 2010 Nov; 59(11):1656-62. PubMed ID: 20423749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance as a novel therapeutic target in patients with chronic kidney disease treated with dialysis.
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Arch Med Wewn; 2010; 120(1-2):54-7. PubMed ID: 20150846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of chronic inflammation in peritoneal dialysis.
    Wang AY
    Semin Nephrol; 2011 Mar; 31(2):159-71. PubMed ID: 21439430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic kidney failure in diabetics with peritoneal dialysis].
    Bednárová V; Sulková S
    Cas Lek Cesk; 1996 May; 135(11):340-3. PubMed ID: 8706069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor 1 enhances renal function in a patient with chronic renal failure on peritoneal dialysis.
    Vijayan A; Franklin SC; Delmez JA; Miller SB
    Am J Kidney Dis; 2000 Jan; 35(1):150-3. PubMed ID: 10620558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality.
    Sánchez-Villanueva R; Estrada P; del Peso G; Grande C; Díez JJ; Iglesias P; González E; Aguilar-Rodríguez A; Selgas R; Bajo MA; ;
    Nefrologia; 2013 Jan; 33(1):85-92. PubMed ID: 23364630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects.
    Yao Q; Wang X; Chung SH; Pecoits-Filho R; Stenvinkel P; Wang T; Heimbürger O; Lindholm B
    Panminerva Med; 2005 Mar; 47(1):19-30. PubMed ID: 15985974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of extrarenal complications of chronic renal insufficiency in patients treated by peritoneal dialysis].
    Simon P
    Nephrologie; 1995; 16(1):77-83. PubMed ID: 7700424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy in patients treated with hemodialysis and peritoneal dialysis: review of the literature and management guidelines].
    Sefer S; Vrsalović M; Degoricija V; Starcević M; Ratković-Gusić I; Delmis J
    Lijec Vjesn; 2002; 124(3-4):82-8. PubMed ID: 18956826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elderly diabetic patients on peritoneal dialysis.
    Passadakis P; Oreopoulos DG
    Adv Perit Dial; 2009; 25():140-6. PubMed ID: 19886336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The blood insulin equilibrium during periodic peritoneal dialysis in chronic renal insufficiency].
    Mirouze J; Mion C; Orsetti A; Jullien C
    J Urol Nephrol (Paris); 1967; 73(10):790-801. PubMed ID: 5596274
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
    Sarafidis PA; Lasaridis AN
    J Cardiometab Syndr; 2008; 3(3):183-7. PubMed ID: 18983337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in chronic uremia.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
    J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal membrane structural and functional changes during peritoneal dialysis.
    Goffin E
    Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.